We suspect the CVS Health change, which goes into effect on July 1, could put a temporary overhang on Eli Lilly shares.
Eli Lilly's earnings beat is clouded by Novo news. What it means for investors
Related Posts
We knew Best Buy’s quarter and guide would be weak. Here’s our plan for the stock
Best Buy ‘s quarter came up short of expectations, with the misses compounded by downward revisions to management’s outlook for the remainder of the year. […]
Palantir (PLTR) earnings Q4 2023
Palantir co-founder and CEO Alex Karp arrives for a U.S. Senate bipartisan Artificial Intelligence Insight Forum at the U.S. Capitol in Washington, D.C., on Sept. […]
Morgan Stanley earnings Q4 2023
The Morgan Stanley headquarters is seen in New York City on Jan. 17, 2023. Michael M. Santiago | Getty Images Morgan Stanley on Tuesday reported […]